欢迎您访问《中华养生保健》官方网站!

中华养生保健 ›› 2024, Vol. 42 ›› Issue (20): 36-40.

• 中医诊疗 • 上一篇    下一篇

宫炎平胶囊联合头孢曲松钠对慢性盆腔炎患者的疗效及对炎症因子的影响

马芳琴   

  1. 岐山县医院质控科,陕西 宝鸡,722400
  • 出版日期:2024-10-16 发布日期:2024-10-14
  • 作者简介:马芳琴(1980—),女,汉族,籍贯:陕西省宝鸡市,本科,主治医师,研究方向:妇科。

The Therapeutic Effect of Gongyanping Capsule Combined with Ceftriaxone Sodium on Patients with Chronic Pelvic Inflammatory Disease and Its Impact on Inflammatory Factors

MA Fang-qin   

  1. Quality Control Department of Qishan County Hospital, Baoji Shaanxi, 722400, China
  • Online:2024-10-16 Published:2024-10-14

摘要: 目的 研究宫炎平胶囊联合头孢曲松钠对慢性盆腔炎患者的疗效及对炎症因子的影响。方法 选择2020年1月—2021年12月岐山县医院收治的100例慢性盆腔炎患者作为研究的对象,应用抽签法将其随机分为对照组和观察组,各50例。对照组单用头孢曲松钠治疗,观察组联用宫炎平胶囊治疗。评估两组的疗效差异,比较两组的盆腔积液量和盆腔附件炎性包块直径,检测两组的血清白细胞介素-6(IL-6)、单核细胞趋化蛋白-1(MCP-1)、C反应蛋白(CRP)、基质金属蛋白酶-2(MMP-2)、白细胞介素-10(IL-10)水平,评估两组的症状评分。结果 观察组的有效率明显高于对照组,差异有统计学意义(P<0.05);治疗后,两组的盆腔积液量和盆腔附件炎性包块直径均明显降低,且观察组更低,差异有统计学意义(P<0.05);治疗后,两组的血清IL-6、MCP-1、CRP水平均明显降低,MMP-2和IL-10水平均明显升高,且观察组的血清IL-6、MCP-1、CRP水平明显更低,MMP-2和IL-10水平明显更高,差异均有统计学意义(P<0.05);治疗后,两组的月经不调、下腹疼痛和带下量多评分均明显降低,且观察组的月经不调、下腹疼痛和带下量多评分明显低于对照组,差异有统计学意义(P<0.05)。结论 宫炎平胶囊联合头孢曲松钠对慢性盆腔炎有显著的疗效,能缓解盆腔组织的粘连状态,减轻机体炎症反应,改善患者的症状,值得临床应用。

关键词: 宫炎平胶囊, 头孢曲松钠, 慢性盆腔炎, 炎症因子

Abstract: Objective To study the therapeutic effect of Gongyanping capsule combined with ceftriaxone sodium on patients with chronic pelvic inflammatory disease. Methods A total of 100 patients with chronic pelvic inflammatory disease admitted to Qishan County Hospital from January 2020 to December 2021 were selected as the study objects, and randomly divided into control group and observation group with 50 cases in each group by drawing lot. The control group was treated with ceftriaxone sodium alone, while the observation group was treated with Gongyanping capsule. To evaluate the efficacy, compare the volume of pelvic fluid accumulation and the diameter of inflammatory masses in pelvic appendages between the two groups, and detect the serum levels of interleukin-6 (IL-6), monocyte chemoattractant protein-1 (MCP-1), C-reactive protein (CRP), matrix metalloproteinase-2 (MMP-2), interleukin-10 (IL-10), and evaluate the symptom scores of both groups of patients. Results The effective rate of the observation group was significantly higher than control group (P<0.05). After treatment, the amount of pelvic fluid accumulation and the diameter of inflammatory masses in pelvic appendages in both groups were significantly reduced (P<0.05), and the observation group were lower (P<0.05). After treatment, the levels of serum IL-6, MCP-1, and CRP in both groups were significantly decreased (P<0.05), while the levels of MMP-2 and IL-10 were significantly increased (P<0.05). The levels of serum IL-6, MCP-1, and CRP in the observation group were significantly lower(P<0.05), while the levels of MMP-2 and IL-10 were significantly higher(P<0.05). After treatment, the scores of menstrual irregularities, lower abdominal pain, and excessive vaginal discharge in both groups were significantly reduced (P<0.05), and the scores of menstrual irregularities, lower abdominal pain, and excessive vaginal discharge in the observation group were significantly lower than those in the control group (P<0.05). Conclusion The combination of Gongyanping Capsules and Ceftriaxone Sodium has a significant therapeutic effect on chronic pelvic inflammatory disease, which can alleviate the adhesion state of pelvic tissue, reduce inflammatory reactions in the body, and improve the symptoms of patients. It is worth application.

Key words: Gong Yanping Capsule, ceftriaxone sodium, chronic pelvic inflammatory disease, inflammatory factors

中图分类号: